Search

Our abstract to the Molecular Pathological Epidemiology 2018 meeting, "Comparison of pre-processing methods to compute PAM50 intrinsic subtype in breast cancer and normal tumor-adjacent regions" was selected for an oral, which was presented by Dr. Heng.

Dr. Heng penned a blog post about her mentee experience with Women Accelerators 2018 Mentoring Program.

Suzanne's abstract "Detection of acini in histopathology slides: towards automatic prediction of breast cancer risk" (Paper 10956-24) has been accepted for an oral at the SPIE Medical Imaging: Digital Pathology Conference 2019!

Dr. A Onken's abstract, "Deep learning networks to segment and detect breast terminal duct lobular units, acini, and adipose tissue: a step toward the automated analysis of lobular involution as a marker for breast cancer risk", submitted to the United States and Canadian Academy of Pathology (USCAP...

This is an informational event to learn about the DF/HCC Cancer Epidemiology Program and the interesting research of a BIDMC program member. Presented by Andrew T. Chan, MD, MPH; A. Heather Eliassen, ScD; and Lorelei Mucci, MPH, ScD – Co-Leaders of the Cancer Epidemiology Program. Dr Heng was the...

Dr. V. FeinZachary's abstract, " Effect of testosterone therapy on breast density in transmasculine individuals: A pilot study" has been accepted for an electronic presentation at the 2022 SBI/ACR Breast Imaging Symposium. Congratulations! See the presentation here.

Dr Wulf, one of Dr Heng's mentor at BIDMC, has been recognised as a nominee for the 2022 ASCO Women Who Conquer Cancer (WWCC) Mentorship Award. https://www.conquer.org/news/conquer-cancer-announces-2022-wwcc-mentorsh... This is a well-deserved achivement for Dr. Wulf. She is an outstanding female...

Dr. Heng was one of the speakers at the BIDMC Precision RNA Medicine Core Detection Workshop, "Tools for the discovery and validation of clinically important microRNA biomarkers” on Friday, April 29 th at 9:00 AM – 10:30 AM ET. The title of her talk was, " “Plasma miRNAs associated with cisplatin...

Congratulations to Dr Baker. Her abstract, "Comparing the Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays Using Definiens, InForm, and QuPath" has been accepted for Poster presentation at the CAP annual meeting 2022.

Transgender Breast Care Working Group, led by Dr. Heng was nominated for the 2023 Group/Program Diversity Award given by Harvard Medical School. Although HMS is unable to honor each nominee with an award, HMS believes that being nominated is an honor unto itself and hope that the team will continue...